The MUC1 aptamer-Dendrimer-epirubicin conjugate and AS1411 aptamer-Dendrimer-epirubicin showed 1802mm3 and 850mm3 of tumor volume after 16 days of treatment. Here, MUC1 is linked to neoplasm.